Tag: 2026
FDA Approves Takeda’s First-in-Class Therapy MIMRYLO for Polycythemia Vera Following Robust Phase 3 Results
Takeda announced that the U.S. Food and Drug Administration (FDA) has approved MIMRYLO, a first-in-class therapy indicated for the treatment of polycythemia vera. Polycythemiavera is a rare, chronic...
Orsini Partners with Priovant to Support Access to New Dermatomyositis Therapy LISRAYA
Orsini, a specialty pharmacy known for its work in rare disease care, has been named a specialty pharmacy partner for LISRAYA (brepocitinib), a newly...
‘Shwas Kavach’ Initiative Gains Government Recognition for AI-Enabled Last-Mile Medical Oxygen Network
Shwas Kavach, an initiative aimed at strengthening India's last-mile medical oxygen supply, has received recognition and support from the Office of the Principal Scientific Adviser (PSA) to...
India’s First AYUSH University to Build 100-Acre Permanent Campus in Kurukshetra, Haryana
The Ministry of Ayush announced the development of the permanent campus for India’s first dedicated AYUSH University, sprawling across nearly 100 acres in Fatehpurvillage, Kurukshetra, Haryana. First announced...
Pfizer-BioNTech’s Updated COVID-19 Vaccine Gets FDA Nod for 2026-2027
Pfizer Inc. and BioNTech SE said Thursday that U.S. regulators have cleared their refreshed COVID-19 shot, giving American providers a strain-matched option just as the fall...
Maharashtra FDA Seizes ₹11.19 Lakh Reactin Plus Stock from Cipla Facility
The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licence of Cipla Pharma & Life Sciences Ltd's Carrying and Forwarding (C&F)...
